Related references
Note: Only part of the references are listed.Comprehensive LC-MSE Lipidomic Analysis using a Shotgun Approach and Its Application to Biomarker Detection and Identification in Osteoarthritis Patients
Jose M. Castro-Perez et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatment
Marc T. Abrams et al.
MOLECULAR THERAPY (2010)
The siRNA sequence and guide strand overhangs are determinants of in vivo duration of silencing
Walter R. Strapps et al.
NUCLEIC ACIDS RESEARCH (2010)
Human CETP aggravates atherosclerosis by increasing VLDL-cholesterol rather than by decreasing HDL-cholesterol in APOE*3-Leiden mice
Jitske de Vries-van der Weij et al.
ATHEROSCLEROSIS (2009)
MicroRNA-like off-target transcript regulation by siRNAs is species specific
Julja Burchard et al.
RNA (2009)
Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models
Susanne Wiklund et al.
ANALYTICAL CHEMISTRY (2008)
Pre-filtering improves reliability of Affymetrix GeneChips results when used to analyze gene expression in complex tissues
Dario Greco et al.
MOLECULAR AND CELLULAR PROBES (2008)
RNAi therapeutics: Principles, prospects and challenges
Lars Aagaard et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia
Marina Cuchel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Regulation of hepatic cholesterol metabolism in CETP+/-/LDLR+/- mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol
Lila M. Harada et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2006)
Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE* 3-Leiden mice
Marit Westerterp et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
RNAi-mediated gene silencing in non-human primates
TS Zimmermann et al.
NATURE (2006)
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
DV Morrissey et al.
NATURE BIOTECHNOLOGY (2005)
Familial hypobetalipoproteinemia: genetics and metabolism
G Schonfeld et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication
DV Morrissey et al.
HEPATOLOGY (2005)
A comprehensive classification system for lipids
E Fahy et al.
JOURNAL OF LIPID RESEARCH (2005)
An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis
RM Crooke et al.
JOURNAL OF LIPID RESEARCH (2005)
Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice
K Wouters et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data
MH Dai et al.
NUCLEIC ACIDS RESEARCH (2005)
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
J Soutschek et al.
NATURE (2004)
Eliminating atherogenesis in mice by switching off hepatic lipoprotein secretion
HD Lieu et al.
CIRCULATION (2003)
Summaries of affymetrix GeneChip probe level data
RA Irizarry et al.
NUCLEIC ACIDS RESEARCH (2003)
2000 George Lyman Duff Memorial Lecture - Atherosclerosis is a liver disease of the heart
RA Davis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Current perspectives on statins
DJ Maron et al.
CIRCULATION (2000)
Share Paper
